Author

S. Connor

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Ecology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:clustering· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

A. Bartlett· 1 shared A. Champreux· 1 shared A. Dabengwa· 1 shared A. Feurdean· 1 shared A. G. Dykema· 1 shared A. J. Munoz· 1 shared A. MacCormick· 1 shared A. Tam· 1 shared

Activity by Year

2017-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bartlett

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Assessing changes in global fire regimes

S. S. Sayedi, B. Abbott, B. Vanniere, B. Leys, D. Colombaroli, G. Gil-Romera, M. Slowinski, J. Aleman, O. Blarquez, A. Feurdean, K. Brown, T. Aakala, T. Alenius, K. Allen, M. Andric, , S. Flantua

This study assesses changes in global fire regimes using expert opinions, finding increased fire regime change rates and future intensification under higher emission scenarios.

bioRxiv · Feb 7, 2023Ecology

Lung tumor-infiltrating Treg have divergent transcriptional profiles and function linked to checkpoint blockade response

A. G. Dykema, J. Zhang, B. Zhang, L. S. Cheung, Z. Zeng, C. M. Cherry, T. Li, J. X. Caushi, M. Nishimoto, S. Connor, Z. Ji, A. J. Munoz, W. Hou, W. Zhan, D. Singh, , K. N. Smith

The paper identifies 10 subsets of lung cancer-infiltrating Tregs, showing one subset is suppressive and linked to anti-PD-1 resistance while another is Th1-like and associated with PD-1 response.

bioRxiv · Dec 13, 2022 · PreprintImmunology

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

B. Lawrence, C. Blenkiron, K. Parker, P. Tsai, S. Fitzgerald, P. Shields, M. L. Yeong, N. Kramer, T. Robb, S. M. James, M. Black, V. Fan, N. Poonawala, P. Yap, E. Coats, , C. G. Print

The paper identifies two distinct aneuploidy patterns in pancreatic neuroendocrine tumors (pNETs) associated with poor and good clinical outcomes, respectively, and highlights MEN1 mutations as a significant driver.

bioRxiv · Nov 8, 2017Cancer Biology